Additional information
| Active substance | Bortezomib |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Blood counts, liver enzymes, and renal function tests should be monitored |
| Also known as | PS-341 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause hypotension or hypertension |
| Trade name | Velcade |
| Storage conditions | Store at 2В°C to 8В°C (36В°F to 46В°F) in original package to protect from light |
| Chemical name | [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid |
| Formula | C19H25BN4O4 |
| Substance class | Proteasome inhibitor |
| Main action | Inhibits the 26S proteasome |
| Half-life | 9 to 15 hours |
| Dosage (medical) | Typically 1.3 mg/m^2 body surface area, administered as an intravenous injection twice a week for two weeks, followed by a 10-day rest period |
| Dosage (sports) | Not applicable |
| Effects | Induces apoptosis and inhibits cell growth and proliferation |
| Side effects | Peripheral neuropathy, fatigue, gastrointestinal disturbances, thrombocytopenia, neutropenia, anemia, pyrexia |
| Use in sports | None |
| Manufacturer | Janssen-Cilag |
FACTIVE 320 mg Abdi Ibragim
Thyromazol 5 mg Abdi Ibragim
Acnegen 20 Bio-Gen
Saizen 12 mg (36 IE) 1,5 ml Wachstumshormon
FUCIDIN 500 mg Abdi Ibragim
Avory Pharma Oral Turinabol 10 mg 100 Kapseln
Fostimon (Merional) 150 IU HMG IBSA
Benelux Pharma CRAZYBULK 40mg 30ml
CLENBOLIC Cooper Pharma
DELETE - Micardis 80 mg Boehringer Ingelheim 

Reviews
There are no reviews yet.